MedSurg and Neurotechnology — Research, development and engineering expenses
Stryker MedSurg and Neurotechnology — Research, development and engineering expenses increased by 0.4% to $247.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.5%, from $205.00M to $247.00M. Over 2 years (FY 2022 to FY 2024), MedSurg and Neurotechnology — Research, development and engineering expenses shows an upward trend with a 7.2% CAGR.
Analysis
How to read this metric
Higher spending suggests a focus on future growth and innovation, whereas lower spending might indicate a focus on short-term margin expansion at the expense of the product pipeline.
Detailed definition
Includes all costs associated with the design, development, and engineering of new products and technologies within the...
Peer comparison
Standard R&D reporting for medical technology firms, often measured as a percentage of segment revenue.
syk_segment_medsurg_and_neurotechnology_research_development_and_engineering_expensesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $170.50M | $170.50M | $170.50M | $170.50M | $175.50M | $175.50M | $175.50M | $175.50M | $195.00M | $194.00M | $205.00M | $190.00M | $226.00M | $246.00M | $247.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.9% | +0.0% | +0.0% | +0.0% | +11.1% | -0.5% | +5.7% | -7.3% | +18.9% | +8.8% | +0.4% |
| YoY Change | — | — | — | — | +2.9% | +2.9% | +2.9% | +2.9% | +11.1% | +10.5% | +16.8% | +8.3% | +15.9% | +26.8% | +20.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's medsurg and neurotechnology — research, development and engineering expenses?
- Stryker (SYK) reported medsurg and neurotechnology — research, development and engineering expenses of $247.00M in Q3 2025.
- How has Stryker's medsurg and neurotechnology — research, development and engineering expenses changed year-over-year?
- Stryker's medsurg and neurotechnology — research, development and engineering expenses increased by 20.5% year-over-year, from $205.00M to $247.00M.
- What is the long-term trend for Stryker's medsurg and neurotechnology — research, development and engineering expenses?
- Over 2 years (2022 to 2024), Stryker's medsurg and neurotechnology — research, development and engineering expenses has grown at a 7.2% compound annual growth rate (CAGR), from $682.00M to $784.00M.
- What does medsurg and neurotechnology — research, development and engineering expenses mean?
- The total spending on innovation and product development for this specific segment.